Reverse Recapitalization (Details)			3 Months Ended					9 Months Ended
	May 24, 2021 $ / shares shares	May 23, 2021	Sep. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Sep. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Sep. 30, 2021 USD ($) $ / shares shares
Business Acquisition [Line Items]
Deemed dividend - Earnout Shares | $								$ 255,822,071
Stock Issued During Period, Shares, New Issues			511,065
Aggregate purchase price | $			$ 1,134,816	$ 1,562,272	$ 6,927,086	$ 1,412,067	$ 177,025
Merger agreement
Business Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues								3,729,730
Merger agreement | Subscription agreements
Business Acquisition [Line Items]
Issue price (in dollars per share) | $ / shares			$ 10.00					$ 10.00
Stock Issued During Period, Shares, New Issues								1,000,000
Aggregate purchase price | $								$ 10,000,000
Merger agreement | Stockholders of NeuroRx
Business Acquisition [Line Items]
Consideration (in shares)	50,000,000
Issue price (in dollars per share) | $ / shares	$ 0.001
Exchange Ratio	3.16	4.96